Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 4
1999 2
2000 3
2001 2
2002 1
2003 2
2004 5
2005 1
2006 2
2007 3
2008 3
2009 1
2011 3
2012 2
2013 1
2014 2
2015 1
2016 7
2017 10
2018 10
2019 4
2020 4
2021 11
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Mansur AH, Fowler SJ, Niven RM, Howarth PH, Lordan JL, Menzies-Gow A, Harrison TW, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID; investigators for the MRC Refractory Asthma Stratification Programme. Heaney LG, et al. Among authors: holweg ctj. Lancet Respir Med. 2021 Jan;9(1):57-68. doi: 10.1016/S2213-2600(20)30397-0. Epub 2020 Sep 8. Lancet Respir Med. 2021. PMID: 32916135 Free PMC article. Clinical Trial.
Roles of Periostin in Respiratory Disorders.
Izuhara K, Conway SJ, Moore BB, Matsumoto H, Holweg CT, Matthews JG, Arron JR. Izuhara K, et al. Among authors: holweg ct. Am J Respir Crit Care Med. 2016 May 1;193(9):949-56. doi: 10.1164/rccm.201510-2032PP. Am J Respir Crit Care Med. 2016. PMID: 26756066 Free PMC article. Review.
A Comprehensive Analysis of the Stability of Blood Eosinophil Levels.
Chipps BE, Jarjour N, Calhoun WJ, Iqbal A, Haselkorn T, Yang M, Brumm J, Corren J, Holweg CTJ, Bafadhel M. Chipps BE, et al. Among authors: holweg ctj. Ann Am Thorac Soc. 2021 Dec;18(12):1978-1987. doi: 10.1513/AnnalsATS.202010-1249OC. Ann Am Thorac Soc. 2021. PMID: 33891831 Free PMC article. Clinical Trial.
Racial/ethnic differences in eligibility for asthma biologics among pediatric populations.
Wohlford EM, Huang PF, Elhawary JR, Millette LA, Contreras MG, Witonsky J, Holweg CTJ, Oh SS, Lee C, Merenda C, Rabin RL, Araojo R, Mak ACY, Eng CS, Hu D, Huntsman S, LeNoir MA, Rodríguez-Santana JR, Borrell LN, Burchard EG. Wohlford EM, et al. Among authors: holweg ctj. J Allergy Clin Immunol. 2021 Nov;148(5):1324-1331.e12. doi: 10.1016/j.jaci.2021.09.005. Epub 2021 Sep 16. J Allergy Clin Immunol. 2021. PMID: 34536416 Free PMC article.
U-BIOPRED: evaluation of the value of a public-private partnership to industry.
Riley JH, Erpenbeck VJ, Matthews JG, Holweg CTJ, Compton C, Seibold W, Higenbottam T, Wagers S, Rowe A, Myles D; Industry Representatives of the U-BIOPRED Study Group. Riley JH, et al. Among authors: holweg ctj. Drug Discov Today. 2018 Sep;23(9):1622-1634. doi: 10.1016/j.drudis.2018.06.015. Epub 2018 Jun 21. Drug Discov Today. 2018. PMID: 29936248 Review.
Response to Omalizumab in Black and White Patients with Allergic Asthma.
Szefler SJ, Jerschow E, Yoo B, Janampally P, Pazwash H, Holweg CTJ, Hudes G. Szefler SJ, et al. Among authors: holweg ctj. J Allergy Clin Immunol Pract. 2021 Nov;9(11):4021-4028. doi: 10.1016/j.jaip.2021.07.013. Epub 2021 Jul 22. J Allergy Clin Immunol Pract. 2021. PMID: 34303017 Free article.
84 results